AbbVie joins the weight loss race
In a $350m deal, AbbVie bought a Danish weight loss drug in Phase 1 clinical trials.
In a $350m deal, AbbVie bought a Danish weight loss drug in Phase 1 clinical trials.
Pharmacies argue the change would let them get out of unfair contracts, while PBMs say the rule could endanger Part D beneficiaries.
Trump’s imposed tariffs could impact patient care and industry finances, experts say.
Over 90% of independent pharmacy owners worry the program would severely hurt their finances, one survey reported.
But the retail pharmacy giant is still expecting high medical costs in 2025, execs warned.
As secretary, Kennedy will oversee tens of thousands of clinicians and scientists.
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.